Silencing the expression of CYP19A1 significantly inhibited the cell proliferation ability and decreased the expression of ER stress-related genes, including ATF4, DDIT3 and XBP1 in STAD. This evidence concerns the gene CYP19A1 and gastric adenocarcinoma.